POLIXENI LIAMOPOULOU

Dr. POLIXENI LIAMOPOULOU


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2019 in Diseases
Verified
Journal Article
Open access
PDF file
Maria LavdanitiMaria Lavdaniti
Maria Lavdaniti
DODimitra Anna Owens
Dimitra Anna Owens
PLPOLIXENI LIAMOPOULOU
POLIXENI LIAMOPOULOU
KMKalliopi Marmara
Kalliopi Marmara
EZEfrosini Zioga
Efrosini Zioga
Eugenia VlachouEugenia Vlachou
Eugenia Vlachou
Purpose: To assess breast cancer patients’ quality of life six months after the completion of adjuvant chemotherapy, and to investigate factors affecting this. Methods: The study was conducted in one large hospital located in a major Greek city. A convenience sample of 61 breast cancer outpatients was recruited. A questionnaire, including the SF-36 scale and questions regarding demographic and clinical information, was used to collect data. Results: The mean age of the patients was 51.52 ± 12.10. The effect of age on the physical role was significant (p = 0.003). Τhe effect of menopausal status on physical role was also found to be significant (p = 0.003); this might be explained by age. Regarding the treatment type, patients who received hormone therapy in addition to surgery and chemotherapy reported a significantly higher quality of life in terms of bodily pain (p = 0.04) and vitality (p = 0.04) than patients who underwent only surgery and chemotherapy. Conclusions: Quality of life is affected by factors such as age, menopausal status, and previous therapy. Health care professionals should be more aware of the factors that influence the quality of life domains (physical role, bodily pain, vitality) within this group of cancer patients in order to meet their needs following acute treatment.

13 February 2026 in Endocrines
Verified
Journal Article
Open access
PDF file
MSMaria Savvidou
Maria Savvidou
IOANNA TSATSOUIOANNA TSATSOU
IOANNA TSATSOU
PLPOLIXENI LIAMOPOULOU
POLIXENI LIAMOPOULOU
PPParaskevi-Maria Prapa
Paraskevi-Maria Prapa
Maria LavdanitiMaria Lavdaniti
Maria Lavdaniti
Background/Objectives: The co-existence of Type 2 Diabetes Mellitus (T2DM) and cancer presents complex self-management challenges due to competing health demands. This study aimed to evaluate and compare self-care activities and adherence to medical recommendations between T2DM patients with cancer and a non-cancer T2DM control group. Additionally, it investigated the impact of sociodemographic and clinical characteristics on treatment adherence. Methods: A cross-sectional study was conducted in a general hospital in Thessaloniki, Greece, using convenience sampling. The sample consisted of 62 participants: 29 patients with T2DM and cancer and 33 controls with T2DM only. Data were collected using the “Diabetes Self-Care Activities Questionnaire”, analyzing subscales for self-care activities and adherence to medical orders. Results: The cancer group was notably older, with a mean age of 69.8 years compared to 60.3 years in the control group (p < 0.001). While overall adherence scores were comparable between groups, significant disparities existed in specific domains. The cancer group demonstrated a critical neglect of foot care recommendations compared to controls (p < 0.001), with a very large effect size (d = 1.60). Conversely, cancer patients reported significantly stricter adherence to dietary recommendations (p = 0.001, d = 0.96). Within the cancer group, older age and lower education were unexpectedly associated with better foot care adherence (p < 0.05). Conclusions: The results suggest a distinct prioritization among cancer patients, whereby they reported maintaining strict dietary adherence while potentially deprioritizing preventative foot care. Clinical practice should consider transitioning to an integrated model where oncology healthcare professionals actively reinforce diabetic foot surveillance to prevent complications.